n-methyl-3,4-methylenedioxyamphetamine has been researched along with Sensation Disorders in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Sensation Disorders: Disorders of the special senses (i.e., VISION; HEARING; TASTE; and SMELL) or somatosensory system (i.e., afferent components of the PERIPHERAL NERVOUS SYSTEM).
| Excerpt | Relevance | Reference |
|---|---|---|
| " The main findings of this study are that: (1) acute MDMA augments locomotor behavior and attenuates the incoming sensory input, (2) chronic treatment of MDMA elicits behavioral sensitization, (3) chronic administration of MDMA results in attenuation of the baseline activity of the sensory evoked field potential, and (4) administration of rechallenge MDMA result in enhancement of the PFC sensory evoked field potential." | 1.35 | MDMA (ecstasy) modulates locomotor and prefrontal cortex sensory evoked activity. ( Atkins, K; Burks, T; Dafny, N; Swann, AC, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, K | 1 |
| Burks, T | 1 |
| Swann, AC | 1 |
| Dafny, N | 1 |
1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Sensation Disorders
| Article | Year |
|---|---|
MDMA (ecstasy) modulates locomotor and prefrontal cortex sensory evoked activity.
Topics: Animals; Auditory Perception; Behavior, Animal; Drug Administration Schedule; Electrodes, Implanted; | 2009 |